Number of patients | Number BRCA1 / 2 deficient | P value | OR (95% CI) | |
---|---|---|---|---|
HRD-LOH score | 197 | 38 | 1.3 × 10-17 | 22 (8.4, 58) |
HRD-TAI score | 197 | 38 | 1.5 × 10-19 | 17 (7.2, 41) |
HRD-LST score | 197 | 38 | 3.5 × 10-18 | 19 (7.7, 46) |
HRD-mean score | 197 | 38 | 1.1 × 10-24 | 90 (22, 360) |
Age at diagnosis | 196 | 37 | 0.0071 | 0.96 (0.94, 0.99) |
Stage | 0.88 | |||
I | 13 | 3 | 1 | |
II | 121 | 23 | 0.78 (0.2, 3.1) | |
III | 54 | 9 | 0.67 (0.15, 2.9) | |
IV | 3 | 1 | 1.7 (0.11, 25) | |
Cancer subtype | 1.2 × 10-5 | |||
TNBC | 52 | 23 | 8.5 (2.3, 31) | |
ER –/HER2 + | 35 | 3 | 1 | |
ER +/HER2 – | 50 | 5 | 1.2 (0.26, 5.3) | |
ER +/HER2 + | 60 | 7 | 1.4 (0.34, 5.8) | |
Gradea (categorical) | 0.0011 | NA | ||
1 | 17 | 0 | 1 | |
2 | 102 | 14 | ∞ (0, ∞) | |
3 | 71 | 21 | ∞ (0, ∞) | |
Grade (numerical) | 0.00053 | 3.1 (1.6, 6.3) |